The Immunity and Infection theme aims to address highly significant local and global health burdens.

The theme maximises it’s interdisciplinary translational research by integration of the KCL Immunology, Infection and Inflammatory Diseases Division and the clinical units of the GSTT and KCH Trusts which form part of the Clinical Academic Grouping in Genetics, Rheumatology, Infection, Immunology, and Dermatology (GRIID) at King’s Health Partners.

Areas of focus

Cluster One – Experimental Medicine and Therapeutics Cluster:

  • Develop enhanced cell therapies for cancer, immune-mediated inflammatory diseases to first-in-man evaluation
  • Generate novel therapeutics for immune-mediated inflammatory diseases

Cluster Two – In the Biomarkers, Co-Diagnostics, Imaging and Devices Cluster:

  • Generate novel diagnostics and prediction-metrics for immune-mediated inflammatory diseases

Lead